Clinical significance of the Monoclonal Gammopathy of Undetermined Significance (MGUS) -like phenotype in patients with AL amyloidosis treated with Bortezomib-Containing Regimens (BCR) at the Amyloidosis Program of Calgary (APC) PA65 (#311)

Amiee Prefontaine

Sylvia McCulloch

Jason Tay

Peter Duggan

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com